Canada markets closed

Ascletis Pharma Inc. (2VJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1480+0.0150 (+11.28%)
At close: 09:59AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 158.27M
Enterprise Value -137.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)19.58
Price/Book (mrq)0.45
Enterprise Value/Revenue -2.42
Enterprise Value/EBITDA 1.09

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3-53.82%
S&P500 52-Week Change 324.19%
52 Week High 30.3060
52 Week Low 30.1290
50-Day Moving Average 30.1682
200-Day Moving Average 30.1906

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 51.01B
Implied Shares Outstanding 61.19B
Float 8189.59M
% Held by Insiders 171.72%
% Held by Institutions 12.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -255.70%
Operating Margin (ttm)-2,260.79%

Management Effectiveness

Return on Assets (ttm)-7.50%
Return on Equity (ttm)-5.93%

Income Statement

Revenue (ttm)56.6M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-36.40%
Gross Profit (ttm)N/A
EBITDA -282.82M
Net Income Avi to Common (ttm)-144.72M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.3B
Total Cash Per Share (mrq)2.17
Total Debt (mrq)8.42M
Total Debt/Equity (mrq)0.36%
Current Ratio (mrq)16.58
Book Value Per Share (mrq)2.21

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A